Literature DB >> 28392416

Aminochrome induces microglia and astrocyte activation.

Cleonice C Santos1, Fillipe M Araújo1, Rafael S Ferreira1, Vanessa B Silva1, Juliana H C Silva1, Maria S Grangeiro1, Érica N Soares1, Érica Patricia L Pereira1, Cleide S Souza1, Silvia L Costa1, Juan Segura-Aguilar2, Victor Diogenes A Silva3.   

Abstract

Aminochrome has been suggested as a more physiological preclinical model capable of inducing five of the six mechanisms of Parkinson's Disease (PD). Until now, there is no evidence that aminochrome induces glial activation related to neuroinflammation, an important mechanism involved in the loss of dopaminergic neurons. In this study, the potential role of aminochrome on glial activation was studied in primary mesencephalic neuron-glia cultures and microglial primary culture from Wistar rats. We demonstrated that aminochrome induced a reduction in the number of viable cells on cultures exposed to concentration between 10 and 100μM. Moreover, aminochrome induces neuronal death determined by Fluoro-jade B. Furthermore, we demonstrated that aminochrome induced reduction in the number of TH-immunoreactive neurons and reactive gliosis, featured by morphological changes in GFAP+ and Iba1+ cells, increase in the number of OX-42+ cells and increase in the number of NF-κB p50 immunoreactive cells. These results demonstrate aminochrome neuroinflammatory ability and support the hypothesis that it may be a better PD preclinical model to find new pharmacological treatment that stop the development of this disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astrogliosis; Dopamine; Microgliosis; Neuroinflammation; Parkinson's disease

Mesh:

Substances:

Year:  2017        PMID: 28392416     DOI: 10.1016/j.tiv.2017.04.004

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  13 in total

Review 1.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

2.  Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.

Authors:  Fillipe Mendes De Araújo; Annyta Fernandes Frota; Lívia Bacelar de Jesus; Ticiane Caribe Macedo; Lorena Cuenca-Bermejo; Consuelo Sanchez-Rodrigo; Kariny Maria Silva Ferreira; Juciele Valéria Ribeiro de Oliveira; Maria de Fatima Dias Costa; Juan Segura-Aguilar; Silvia Lima Costa; Maria Trinidad Herrero; Victor Diógenes Amaral Silva
Journal:  Cell Mol Neurobiol       Date:  2022-01-06       Impact factor: 5.046

3.  JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species.

Authors:  Cleonice Creusa Santos; Thyago R Cardim-Pires; Liana Shvachiy; Luis Arturo Fonseca-Fonseca; Patricia Muñoz; Áurea Maria A N Almeida; Ana Carla S Costa; Jéssica Teles-Souza; Estael Ochoa-Rodríguez; Maria de Fátima Dias Costa; Fernando L Palhano; Juan Segura-Aguilar; Deyse B Barbosa; Mayra R do Bomfim; Manoelito C Dos Santos Junior; Franco Henrique A Leite; Samuel Silva da Rocha Pita; Silvia Lima Costa; Yanier Núñez-Figueredo; Tiago Fleming Outeiro; Débora Foguel; Victor Diogenes Amaral Silva
Journal:  Neurotox Res       Date:  2022-08-23       Impact factor: 3.978

4.  Astrocyte Reaction to Catechol-Induced Cytotoxicity Relies on the Contact with Microglia Before Isolation.

Authors:  Julita Maria Pereira Borges; Lívia Bacelar de Jesus; Cleide Dos Santos Souza; Victor Diogenes Amaral da Silva; Silvia Lima Costa; Maria de Fátima Dias Costa; Ramon Santos El-Bachá
Journal:  Neurotox Res       Date:  2022-06-16       Impact factor: 3.978

5.  Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease.

Authors:  David Sulzer; Fabio A Zucca; Luigi Zecca
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-06

6.  Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic.

Authors:  Sandro Huenchuguala; Birgitta Sjödin; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-10-20       Impact factor: 3.911

7.  Cellular Trafficking of Glutathione Transferase M2-2 Between U373MG and SHSY-S7 Cells is Mediated by Exosomes.

Authors:  Raúl Valdes; Alicia Armijo; Patricia Muñoz; Kjell Hultenby; Andres Hagg; Jose Inzunza; Ivan Nalvarte; Mukesh Varshney; Bengt Mannervik; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2021-02-08       Impact factor: 3.911

8.  Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease.

Authors:  Juan Segura-Aguilar; Sandro Huenchuguala
Journal:  Front Neurosci       Date:  2018-03-13       Impact factor: 4.677

Review 9.  Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system.

Authors:  Nils Lannes; Elisabeth Eppler; Samar Etemad; Peter Yotovski; Luis Filgueira
Journal:  Oncotarget       Date:  2017-12-11

Review 10.  On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease.

Authors:  Juan Segura-Aguilar
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.